Li, Xinnong http://orcid.org/0009-0009-3002-4146
Sale, Mark http://orcid.org/0000-0002-6239-2359
Nieforth, Keith
Craig, James http://orcid.org/0000-0003-1757-9234
Wang, Fenggong
Solit, David
Feng, Kairui
Hu, Meng http://orcid.org/0000-0003-2719-3263
Bies, Robert http://orcid.org/0000-0003-3818-2252
Zhao, Liang http://orcid.org/0000-0002-0257-9082
Funding for this research was provided by:
FDA/NIH (1U01FD007355)
Article History
Received: 11 April 2024
Accepted: 12 June 2024
First Online: 28 June 2024
Declarations
:
: Informed consent was obtained from all participants for the original clinical study.
: M Sale, J Craig and K Nieforth are employees of Certara USA. Dr. Bies receives grant funding from NIDA, NIAID, NICHE, USAID, Bill and Melinda Gates Foundation and serves as a consultant for Advanced Biosciences Laboratories (NIAID). In the past he has served as a consultant for Lumos Biopharma through NGT Biopharma Consultants and St. Gobain Corporation.